← Back to headlines
EyePoint Sues Ocular Over Lead Asset Claims
EyePoint Pharmaceuticals has filed a lawsuit against Ocular Therapeutix, alleging claims related to its lead asset.
21 Mar, 14:23 — 21 Mar, 14:23
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Agricultural Company Files Cyberlibel, Defamation Complaints Against Farmers' Groups
just now
Philippine ERC suspends electricity disconnections amid rising costs
just now
Oriental Mindoro Jeepney Drivers Receive Government Cash Aid
just now